Lachmann P
J Med Genet. 1975 Dec;12(4):372-7. doi: 10.1136/jmg.12.4.372.
The complement system, unlike the coagulation system, was largely characterized by in-vitro techniques which did not make use of genetically deficient plasmas. The existence of the genetically deficient plasmas. The existence of the genetically deficient subjects therefore has served largely to increase our knowledge of the in-vivo role of complement. At the present time its clearest role is in the resistance to infection; obviously in the case of C3 deficiency and bacterial infection and possibly more subtly in the case of deficiency of the early active complement components and low virulence organisms. There is so far no evidence that genetic complement deficiency interferes with antibody formation or with the generation of tolerance as has been suggested in the pas (Azar et al, 1968; Dukor and Hartmann, 1973).
与凝血系统不同,补体系统很大程度上是通过未使用基因缺陷血浆的体外技术来表征的。基因缺陷血浆的存在。因此,基因缺陷受试者的存在在很大程度上有助于增加我们对补体体内作用的认识。目前,其最明显的作用是抗感染;显然在C3缺乏和细菌感染的情况下,在早期活性补体成分缺乏和低毒力生物体的情况下可能更微妙。到目前为止,尚无证据表明基因补体缺陷会干扰抗体形成或如过去所建议的那样干扰耐受性的产生(阿扎尔等人,1968年;杜科尔和哈特曼,1973年)。